UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Von Willebrand Disease: Gaining a global perspective

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-07, Vol.29 (4), p.1104-1112

2023

Volltextzugriff (PDF)

The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population

BMC medical genomics, 2019-01, Vol.12 (1), p.11-11, Article 11

2019

Volltextzugriff (PDF)

Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease

Human molecular genetics, 2013-02, Vol.22 (4), p.769-781

2013

Volltextzugriff (PDF)

Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B

Journal of Blood Medicine, 2016-01, Vol.7, p.275-282

Djambas Khayat, Claudia

2016

Volltextzugriff (PDF)

Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome

Leukemia research reports, 2021-01, Vol.16, p.100277, Article 100277

2021

Volltextzugriff (PDF)

Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus

Blood coagulation & fibrinolysis, 2018-09, Vol.29 (6), p.509-520

2018

Volltextzugriff (PDF)

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

Blood, 2021-06, Vol.137 (22), p.3127-3136

2021

Volltextzugriff (PDF)

The impact of haemophilia on the social status and the health‐related quality of life in adult Lebanese persons with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.264-269

2019

Volltextzugriff (PDF)

Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-11, Vol.28 (6), p.1022-1032

2022

Volltextzugriff (PDF)

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients

Journal of thrombosis and haemostasis, 2020-04, Vol.18 (4), p.815-824

2020

Volltextzugriff (PDF)

Heavy menstrual bleeding in women with inherited bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-04, Vol.26 (S3), p.16-19

2020

Volltextzugriff (PDF)

Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia

Thrombosis and haemostasis, 2020-06, Vol.120 (6), p.957-967

2020

Volltextzugriff (PDF)

Efficacy and safety of fibrinogen concentrate for on‐demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-03, Vol.27 (2), p.283-292

2021

Volltextzugriff (PDF)

Clinical pharmacology, efficacy and safety study of a triple‐secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency

Journal of thrombosis and haemostasis, 2019-04, Vol.17 (4), p.635-644

2019

Volltextzugriff (PDF)

Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial

Transfusion (Philadelphia, Pa.), 2018-02, Vol.58 (2), p.413-422

2018

Volltextzugriff (PDF)

von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease

Blood advances, 2024-03, Vol.8 (6), p.1405-1414

2024

Volltextzugriff (PDF)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)

Journal of blood medicine, 2020-01, Vol.11, p.213-225

2020

Volltextzugriff (PDF)

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)

Journal of blood medicine, 2021-01, Vol.12, p.483-495

2021

Volltextzugriff (PDF)

Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.5485-5485

2023

Volltextzugriff (PDF)

Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate

Blood, 2023-11, Vol.142 (Supplement 1), p.5510-5510

2023

Volltextzugriff (PDF)

Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Children and Adolescents with Von Willebrand Disease - a Sub-Analysis of Data from the Wil-31 Study

Blood, 2023-11, Vol.142 (Supplement 1), p.3992-3992

2023

Volltextzugriff (PDF)

Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Heavy Menstrual Bleeding in Females with Von Willebrand Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.3997-3997

2023

Volltextzugriff (PDF)

Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.5509-5509

2023

Volltextzugriff (PDF)

Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA‐02 and FORMA‐04 clinical trials

Transfusion (Philadelphia, Pa.), 2022-09, Vol.62 (9), p.1871-1881

2022

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(41)
Berichte
(2)

Sprache

Englisch
(43)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Von Willebrand Disease: Gaining a global perspective

The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population

Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease

Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B

Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome

Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus

Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia

The impact of haemophilia on the social status and the health‐related quality of life in adult Lebanese persons with haemophilia

Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients

Heavy menstrual bleeding in women with inherited bleeding disorders

Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia

Efficacy and safety of fibrinogen concentrate for on‐demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency

Clinical pharmacology, efficacy and safety study of a triple‐secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiency

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial

von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)

Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease

Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate

Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Children and Adolescents with Von Willebrand Disease - a Sub-Analysis of Data from the Wil-31 Study

Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Heavy Menstrual Bleeding in Females with Von Willebrand Disease

Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease

Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA‐02 and FORMA‐04 clinical trials

Suchergebnisse filtern